FDA Women’s Health Initiative Advisory Committee Meeting Postponed

The Nov. 12-13 meeting of the Women's Health Initiative Subcommittee of FDA's Reproductive Health Drugs Advisory Committee has been postponed

More from Archive

More from Pink Sheet